tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Shanghai MicroPort MedBot Reports Strong Revenue Growth and Narrowed Losses in H1 2025

Story Highlights
Shanghai MicroPort MedBot Reports Strong Revenue Growth and Narrowed Losses in H1 2025

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Shanghai MicroPort MedBot (Group) Co., Ltd. Class H ( (HK:2252) ) just unveiled an update.

Shanghai MicroPort MedBot reported a significant increase in revenue by 77% to RMB175.7 million for the first half of 2025, driven by the rapid commercialization of its surgical robots, particularly in overseas markets. Despite a net loss of RMB114.9 million, the company successfully narrowed its losses by 58.9% compared to the previous year, attributed to strategic cost reductions and efficiency improvements, alongside a decrease in net free cash outflow by 42.8% due to reduced net loss and completion of fixed asset investments.

The most recent analyst rating on (HK:2252) stock is a Hold with a HK$19.10 price target. To see the full list of analyst forecasts on Shanghai MicroPort MedBot (Group) Co., Ltd. Class H stock, see the HK:2252 Stock Forecast page.

More about Shanghai MicroPort MedBot (Group) Co., Ltd. Class H

Shanghai MicroPort MedBot (Group) Co., Ltd. is a joint stock company based in China, specializing in the development and commercialization of surgical robots. The company’s primary products include the Toumai Laparoscopic Surgical Robot, SkyWalker Orthopedic Surgical Robot, and R-ONE Vascular Interventional Surgical Robot, with a strong market focus on both domestic and international regions.

Average Trading Volume: 7,600,445

Technical Sentiment Signal: Buy

Current Market Cap: HK$21B

See more data about 2252 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1